Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vimta LabsBOM:524394 +3.58%84 OCF Yield % is 5.49 as of Aug. 05, 2026. GuruFocus rates BOM:524394 with a GF Score™ of 84/100 and a GF Value™ of ₹495.16 (Modestly Overvalued). The stock has 1 warning sign investors should review. Among 213 Medical Diagnostics & Research companies, Vimta Labs ranks better than 71.83% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Vimta Labs's OCF Yield % or its related term are showing as below:
BOM:524394'
s OCF Yield % Range Over the Past 10 Years
Min: 5.49 Med: 0 Max: 5.49
Current: 5.49
During the past 13 years, the highest OCF Yield % of Vimta Labs was 5.49%. The lowest was 5.49%. And the median was %.
BOM:524394's OCF Yield % is ranked better than 71.83% of 213
companies
in the Medical Diagnostics & Research industry
Industry Median: 1.14
vs BOM:524394: 5.49
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Vimta Labs OCF Yield % Related Terms
Vimta Labs OCF Yield % Historical Data
* Premium members only.
The historical data trend for Vimta Labs's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:524394 vs TMO, DHR, IDXX: OCF Yield % Comparison
For the Diagnostics & Research subindustry, Vimta Labs's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vimta Labs OCF Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Vimta Labs's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Vimta Labs's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vimta Labs (BOM:524394) has a OCF Yield % of 5.49 as of Aug. 05, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Vimta Labs and its competitors. Over the past decade, Vimta Labs' OCF Yield % has ranged from 5.49 to 5.49. According to the industry distribution chart, Vimta Labs ranks #60 out of 213 companies in the Medical Diagnostics & Research industry, placing it in the top 28.2%.
Is Vimta Labs' OCF Yield % too high?
Vimta Labs' current OCF Yield % is 5.49. Over the past 10 years, this metric has ranged from a low of 5.49 to a high of 5.49. The Medical Diagnostics & Research industry median OCF Yield % is 1.14. Vimta Labs' value of 5.49 is 381.6% above this industry median. Based on the distribution chart, Vimta Labs ranks #60 out of 213 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Vimta Labs has a GF Score™ of 84/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vimta Labs' OCF Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Vimta Labs ranks #60 out of 213 companies for OCF Yield %. This puts Vimta Labs in the upper half of its industry. The industry median OCF Yield % is 1.14. Vimta Labs' value of 5.49 is 381.6% above this benchmark. Historically, Vimta Labs' own OCF Yield % has ranged from 5.49 to 5.49 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Diagnostics & Research company?
The median OCF Yield % among Medical Diagnostics & Research companies is 1.14, based on 213 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vimta Labs's current OCF Yield % of 5.49 is 381.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Vimta Labs and its competitors. For the Medical Diagnostics & Research industry, the median OCF Yield % is 1.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vimta Labs's current OCF Yield % is 5.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vimta Labs stock overvalued right now?
Based on GuruFocus' analysis, Vimta Labs (BOM:524394) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹495.16, compared to a current price of ₹641.20 — trading 29.5% above its estimated fair value. The current OCF Yield % is 5.49 and 381.6% above the Medical Diagnostics & Research industry median of 1.14. Vimta Labs' overall GF Score™ is 84/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Vimta Labs (BOM:524394), the current OCF Yield % is 5.49 as of Aug. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vimta Labs (BOM:524394) Overvalued in 2026?
Based on GuruFocus' analysis, Vimta Labs stock appears to be overvalued.
The current stock price of ₹641.20 is trading 29.5% above its estimated GF Value™ of ₹495.16.
GuruFocus considers Vimta Labs to be Modestly Overvalued.
Key valuation signals for BOM:524394:
OCF Yield %: 5.49
GF Value™: ₹495.16 vs. price of ₹641.20 (29.5% above fair value)
Industry Position: 381.6% above the Medical Diagnostics & Research median (#60 of 213)
No single metric tells the full story. See the BOM:524394 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vimta Labs Ltd is a comprehensive contract research and testing organization, providing a wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device, and many other industries. Its services portfolio includes testing and contract research services in the fields of clinical research, pre-clinical research, clinical diagnostics, biopharma services, analytical testing, research and environmental studies, and Others. It has only one reportable segment namely Contract Research and Testing Services which generates the revenue.
84GF Score
Get the complete analysis for BOM:524394
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524394 has been successfully added to your 
